These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29845543)

  • 21. Towards antiviral therapies for treating dengue virus infections.
    Kaptein SJ; Neyts J
    Curr Opin Pharmacol; 2016 Oct; 30():1-7. PubMed ID: 27367615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dengue structural proteins as antiviral drug targets: Current status in the drug discovery & development.
    S AH; Pujar GV; Sethu AK; Bhagyalalitha M; Singh M
    Eur J Med Chem; 2021 Oct; 221():113527. PubMed ID: 34020338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of antiviral molecules for dengue: In silico search and biological evaluation.
    Cabarcas-Montalvo M; Maldonado-Rojas W; Montes-Grajales D; Bertel-Sevilla A; Wagner-Döbler I; Sztajer H; Reck M; Flechas-Alarcon M; Ocazionez R; Olivero-Verbel J
    Eur J Med Chem; 2016 Mar; 110():87-97. PubMed ID: 26807547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting dengue virus NS4B protein for drug discovery.
    Xie X; Zou J; Wang QY; Shi PY
    Antiviral Res; 2015 Jun; 118():39-45. PubMed ID: 25796970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An iminosugar with potent inhibition of dengue virus infection in vivo.
    Perry ST; Buck MD; Plummer EM; Penmasta RA; Batra H; Stavale EJ; Warfield KL; Dwek RA; Butters TD; Alonzi DS; Lada SM; King K; Klose B; Ramstedt U; Shresta S
    Antiviral Res; 2013 Apr; 98(1):35-43. PubMed ID: 23376501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retro peptide-hybrids as selective inhibitors of the Dengue virus NS2B-NS3 protease.
    Nitsche C; Behnam MA; Steuer C; Klein CD
    Antiviral Res; 2012 Apr; 94(1):72-9. PubMed ID: 22391061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small molecule drug discovery for Dengue and West Nile viruses: applying experience from hepatitis C virus.
    Parkinson T; Pryde DC
    Future Med Chem; 2010 Jul; 2(7):1181-203. PubMed ID: 21426163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture.
    Raut R; Beesetti H; Tyagi P; Khanna I; Jain SK; Jeankumar VU; Yogeeswari P; Sriram D; Swaminathan S
    Virol J; 2015 Feb; 12():16. PubMed ID: 25886260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-guided Discovery of a Novel Non-peptide Inhibitor of Dengue Virus NS2B-NS3 Protease.
    Li L; Basavannacharya C; Chan KW; Shang L; Vasudevan SG; Yin Z
    Chem Biol Drug Des; 2015 Sep; 86(3):255-64. PubMed ID: 25533891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. True Blood: dengue virus evolution.
    Wash R; Soria CD
    Nat Rev Microbiol; 2015 Nov; 13(11):662. PubMed ID: 26439086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleobases and corresponding nucleosides display potent antiviral activities against dengue virus possibly through viral lethal mutagenesis.
    Qiu L; Patterson SE; Bonnac LF; Geraghty RJ
    PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006421. PubMed ID: 29672522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigational drugs in early development for treating dengue infection.
    Beesetti H; Khanna N; Swaminathan S
    Expert Opin Investig Drugs; 2016 Sep; 25(9):1059-69. PubMed ID: 27322111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drugs for dengue: a patent review (2010-2014).
    Beesetti H; Khanna N; Swaminathan S
    Expert Opin Ther Pat; 2014 Nov; 24(11):1171-84. PubMed ID: 25283170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppressive Effects of the Site 1 Protease (S1P) Inhibitor, PF-429242, on Dengue Virus Propagation.
    Uchida L; Urata S; Ulanday GE; Takamatsu Y; Yasuda J; Morita K; Hayasaka D
    Viruses; 2016 Feb; 8(2):. PubMed ID: 26875984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Important advances in the field of anti-dengue virus research.
    Julander JG; Perry ST; Shresta S
    Antivir Chem Chemother; 2011; 21(3):105-16. PubMed ID: 21233532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of Potent Non-nucleoside Inhibitors of Dengue Viral RNA-Dependent RNA Polymerase from Fragment Screening and Structure-Guided Design.
    Lim SP; Noble CG; Nilar S; Shi PY; Yokokawa F
    Adv Exp Med Biol; 2018; 1062():187-198. PubMed ID: 29845534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testing antiviral compounds in a dengue mouse model.
    Schul W; Yip A; Shi PY
    Methods Mol Biol; 2013; 1030():269-81. PubMed ID: 23821275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus.
    Yang CC; Tsai MH; Hu HS; Pu SY; Wu RH; Wu SH; Lin HM; Song JS; Chao YS; Yueh A
    Antiviral Res; 2013 May; 98(2):228-41. PubMed ID: 23499649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sophoraflavenone G Restricts Dengue and Zika Virus Infection via RNA Polymerase Interference.
    Sze A; Olagnier D; Hadj SB; Han X; Tian XH; Xu HT; Yang L; Shi Q; Wang P; Wainberg MA; Wu JH; Lin R
    Viruses; 2017 Oct; 9(10):. PubMed ID: 28972551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities.
    Pelliccia S; Wu YH; Coluccia A; La Regina G; Tseng CK; Famiglini V; Masci D; Hiscott J; Lee JC; Silvestri R
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1091-1101. PubMed ID: 28776445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.